Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Return on Assets: 2011-2025

Historic Return on Assets for Lifecore Biomedical (LFCR) over the last 13 years, with May 2025 value amounting to -0.16%.

  • Lifecore Biomedical's Return on Assets fell 17.00% to -0.16% in Q2 2025 from the same period last year, while for May 2025 it was -0.16%, marking a year-over-year decrease of 17.00%. This contributed to the annual value of -0.16% for FY2025, which is 17.00% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Return on Assets of -0.16% as of Q2 2025, which was down 6.53% from -0.15% recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical's Return on Assets peaked at 0.01% during Q2 2024, and registered a low of -0.40% during Q3 2022.
  • Over the past 3 years, Lifecore Biomedical's median Return on Assets value was -0.11% (recorded in 2023), while the average stood at -0.11%.
  • As far as peak fluctuations go, Lifecore Biomedical's Return on Assets crashed by 37bps in 2022, and later skyrocketed by 33bps in 2024.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Return on Assets stood at -0.13% in 2021, then dropped by 12bps to -0.24% in 2022, then increased by 14bps to -0.10% in 2023, then climbed by 2bps to -0.09% in 2024, then dropped by 17bps to -0.16% in 2025.
  • Its Return on Assets stands at -0.16% for Q2 2025, versus -0.15% for Q1 2025 and -0.09% for Q4 2024.